Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-12-7
|
pubmed:language |
cze
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0069-2336
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
188-96
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2889532-Adult,
pubmed-meshheading:2889532-Anti-Anxiety Agents,
pubmed-meshheading:2889532-Anxiety Disorders,
pubmed-meshheading:2889532-Benzodiazepines,
pubmed-meshheading:2889532-Female,
pubmed-meshheading:2889532-Humans,
pubmed-meshheading:2889532-Male,
pubmed-meshheading:2889532-Middle Aged,
pubmed-meshheading:2889532-Oxazepam
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Comparison of tofizopam with oxazepam in the treatment of anxiety neuroses].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|